News
Inovus Medical has taken its total funding to US$20m (£15m) as the St Helens surgical training firm expands internationally.
People with COPD across North West London will be offered daily AI support through a six-month programme involving six primary care networks. The programme begins this month, introducing Aide Health’s app across Celandine Health and MetroCare PCN, North Connect PCN, NeoHealth PCN, Regent Health PCN, St John’s Wood and Maida Vale PCN and Westminster Living [...]
A phase 3 retatrutide trial found reduced body weight, improved blood sugar and lower inflammation markers in adults with obesity and type 2 diabetes. The drug, which is not yet approved by any regulatory agency, mimics three gut hormones involved in appetite, blood sugar and metabolism: GLP-1, GIP and glucagon. Unlike drugs that target GLP-1 [...]
EliseAI has raised US$350m in a round valuing the AI firm at US$4bn, expanding its automation tools for housing and healthcare systems.
AXREM has partnered with Silver Buck to provide members with webinars, workshops and guidance on healthcare marketing, PR and communications. The partnership will cover healthcare marketing, public relations, stakeholder engagement and communications best practice. Silver Buck will work with AXREM on a programme of educational activities for members. AXREM represents UK suppliers of diagnostic medical [...]
Executives, digital, operational, and frontline staff from the newly integrated North Cheshire and Mersey NHS Foundation Trust, will welcome both big tech and innovative health tech firms on 27 November. The trust, which integrated in April, is the latest in the NHS to host Elevate – a programme of health tech showcases that bring curated [...]
By Joanne Meredith, senior patent attorney, HGF For many medical technology companies, a patent is the natural starting point when considering intellectual property protection for a new product. The technology is new, the invention is technical and the commercial instinct is therefore to ask: what can we patent? But that question may be too narrow. [...]
GE HealthCare and Mass General Brigham are building a generative AI tool to help radiotherapy teams navigate fragmented patient data and speed up treatment.
DYAD has raised US$10m to expand its healthcare AI across the NHS and into new markets, including secondary care and mental health services. The Series A closed in April 2026 and will support a wider rollout of the UK company's technology across primary care and other healthcare settings. DYAD develops technology that turns information in [...]
NHS restructuring is undermining the health service's capacity to adopt digital innovation, a think tank has warned, leaving suppliers unsure who to deal with.
